Ignite Creation Date:
2024-05-05 @ 11:56 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00184028
Status:
TERMINATED
Last Update Posted:
2014-05-22
First Post:
2005-09-12
Brief Title:
Combination of Taxotere and Oxaliplatin in Squamous Cell Carcinoma of the Head and Neck
Sponsor:
University of Southern California
Organization:
University of Southern California
Study Overview
Official Title:
Phase II Trial of Taxotere and Oxaliplatin Combination Chemotherapy in Squamous Cell Carcinoma of the Head and Neck
Status:
TERMINATED
Status Verified Date:
2014-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Insufficient Accrual
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This research study is for subjects with squamous cell cancer of the head and neck which is not solely treatable with surgery or radiation This research study involves treatment with an experimental chemotherapy combination of oxaliplatin and Taxotere Tha main purpose of this study is to assess the effectiveness of this combination of medications for this type of cancer
Approximately 54 subjects will take part in this study
Approximately 54 subjects will take part in this study
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None